Avista Expands European Consumer Health Play with Sanotact Acquisition
Event summary
- Avista Healthcare Partners completed its acquisition of German VMS platform sanotact Group GmbH on July 1, 2026.
- Sanotact operates a contract manufacturing (CDMO) business alongside branded vitamin/mineral/supplement products.
- The deal marks Avista's ninth consumer healthcare platform investment and expands its partnership with Damier Group.
- Sanotact serves customers across 80 international markets from its Münster headquarters.
The big picture
This acquisition continues the consolidation trend in European consumer healthcare, with private equity firms building scale through platform investments. Avista's $10B+ AUM positions it to compete aggressively in the space, particularly as demand for preventive health products grows. The deal extends a strategic relationship with Damier Group that has produced multiple successful consumer health platforms.
What we're watching
- Integration Strategy
- How Avista will leverage sanotact's CDMO capabilities to drive cross-platform synergies within its consumer healthcare portfolio.
- European Expansion
- Whether sanotact can accelerate international growth beyond its established German market presence.
- M&A Pipeline
- The pace at which Avista pursues additional European consumer health acquisitions through the Damier Group partnership.
Related topics